Baird analyst Daniel Leben said he views Halliburton's (HAL) delayed conference call and its stated decision to move away from maintaining greater-than-required operational capacity as signs the company's deal with Baker Hughes (BHI) will break after April 30. Leben, who expects Halliburton to remain acquisitive, but does not expect anything in the near-term as the company works through additional restructuring, keeps a Neutral rating and $38 price target on Halliburton shares.

Unusual total active option classes on open include: ImmunityBio (IBRX), Halliburton (HAL), Redfin (RDFN), Nokia (NOK), Matterport (MTTR), General Motors (GM), UPS (UPS), Philip Morris (PM), PepsiCo (PEP), and General Electric (GE).

Reports Q1 revenue $5.8B, consensus $5.67B. "Halliburton delivered solid first quarter results that again demonstrated the power of our strategy and the strength of our execution. Activity in North America recovered from fourth-quarter lows, and our international business delivered its 11th consecutive quarter of year-on-year growth," commented Jeff Miller, Chairman, President and CEO. "Our customers' multi-year activity plans across markets and asset types confirms my confidence in the strength and duration of this upcycle. Halliburton demonstrated its commitment to shareholder returns in the first quarter and repurchased $250 million of common stock - a solid start to the year and a good benchmark for our expectations going forward," concluded Miller.